STOML2 has been described as a positive regulator of cancer cell growth; its increased expression is associated with esophageal precancers and its expression has been reported as increasing with invasive disease stages in laryngeal squamous cell carcinomas 24,26. This evidence concerns the gene STOML2 and cancer.